Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 4.1.2023Gedeon Richter Plc. (GDN)24007QUAMATEL (plv iol 5x20 mg+5x5 ml solv. (liek.inj.skl.+amp.))5.1.2023O
 4.1.2023Gedeon Richter Plc. (GDN)26460SUPRAX (plv sus 1x50 ml/1 g (fľ.skl.))5.1.2023O
 4.1.2023Gedeon Richter Plc. (GDN)26461SUPRAX (tbl flm 10x200 mg (blis.PVC/PVDC/Al))5.1.2023O
 4.1.2023Gedeon Richter Plc. (GDN)82949GYNAZOL 2 % vaginálny krém (crm vag 1x5 g)5.1.2023O
 4.1.2023ARDEZ Pharma, spol. s r.o. (ARZ)2436DTedez (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))1.2.2023R
 4.1.2023Mylan IRE Healthcare Limited (MYR)7022ACholib 145 mg/40 mg filmom obalené tablety (tbl flm 30x145 mg/40 mg (blis.Al/Al))5.1.2023O
 4.1.2023CANDE s.r.o. (CRR-SK)5386CALFAMED 1,0 mikrogram (cps mol 90x1 µg (fľ.HDPE s PP uzáver.))4.1.2023R
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)2934AMigralgin (tbl 1x20 (blis.PVC/PVDC/Al-nepriehľ.s termo-tvarov.vrstvou))9.1.2023O
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)83090MAGNE-B6 sol por (sol por 10x10 ml (amp.skl.hnedá))5.1.2023O
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)26419PARALEN 500 SUP (sup 5x500 mg (strip Al))4.1.2023R
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)27613PARALEN 100 (sup 5x100 mg (strip Al))10.1.2023R
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)4548CEssentiale forte 600 mg (cps dur 30x600 mg (blis.PVC/PVDC/Al))9.1.2023R
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)66101PARALEN SUS (sus por 1x100 ml (fľ.skl.hnedá))10.1.2023R
 4.1.2023Opella Healthcare Slovakia s.r.o. (OPL)92031Bronchicum (sol por 1x100 ml/130 g (fľ.skl.))10.1.2023R
 4.1.2023Viatris Limited (VIM)9997COgivri 150 mg prášok na infúzny koncentrát (plc ifc 1x150 mg (liek.inj.skl.))5.1.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To